Endo Exec Ripped FDA 'Window Dressing,' Jury Hears
A former Endo regulatory affairs executive was confronted Wednesday in the New York opioid trial with an email in which he had called a major FDA opioid risk mitigation project "window...To view the full article, register now.
Already a subscriber? Click here to view full article